Replies to post #43411 on Biotech Values

[DewDiligence]

Re: Court rules against Pfizer on Norvasc patent case

This is excellent news for Novartis. Why NVS? I’ll make that a quiz :-)

p.s. The answer is not that NVS plans to launch a generic version of Norvasc.